Novo CEO pressed by Senate to cut price ranges of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would think about new talks with insurers regarding the listing selling prices of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://daveshotchickennutrition85295.activoblog.com/31758154/healthcare-news-an-overview